STOCK TITAN

AMBASE CORP 10-Q Filings

ABCP OTC

Every 10-Q that AMBASE CORP (ABCP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow ABCP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ABCP filings page.

Rhea-AI Summary

AmBase Corporation reported continued operating losses for the quarter ended June 30, 2026 while remaining focused on litigation tied to its former equity interest in the 111 West 57th Street real estate project. Operating expenses for the quarter were $705 thousand, leading to a quarterly net loss of $736 thousand; for the first six months of 2026, the net loss was $1.51 million, compared with $2.68 million in the prior-year period.

The balance sheet is extremely thin: total assets were $98 thousand, entirely cash and cash equivalents, against total liabilities of $2.29 million plus $8.0 million of related-party litigation funding obligations, resulting in a stockholders’ deficit of $10.20 million as of June 30, 2026. The company discloses that it has no operating revenues and manages its business as a single segment focused on managing its assets and liabilities and pursuing legal proceedings related to the 111 West 57th Property.

Management states there is substantial doubt about AmBase’s ability to continue as a going concern over the next 12 months, given recurring losses, negative operating cash flow of $2.37 million in the first half of 2026, and minimal cash reserves. To fund operations and litigation, AmBase relies heavily on loans and litigation funding agreements from its chairman and an affiliated entity, under which up to $6.0 million from the chairman and $2.0 million from the affiliate are committed and will be repaid from any future litigation proceeds before shareholders participate.

Rhea-AI Summary

AmBase Corporation reported a net loss of $775 thousand for the three months ended March 31, 2026, narrowing from a $1,592 thousand loss a year earlier. Operating expenses fell to $678 thousand from $1,537 thousand, mainly on sharply lower professional and outside services.

Cash and cash equivalents increased to $533 thousand from $87 thousand at December 31, 2025, helped by related-party financing and new litigation funding. Total liabilities were $2,493 thousand, and stockholders’ equity was a deficit of $9,460 thousand. Management states there is substantial doubt about the Company’s ability to continue as a going concern without additional capital.

The business is effectively a single litigation-driven segment centered on disputes over the 111 West 57th Property. In March 2026, AmBase converted $4,000 thousand of loans from its CEO and $2,000 thousand from affiliate BARC into litigation funding agreements and secured further funding commitments tied to potential recoveries, which will reduce the Company’s share of any future litigation proceeds.

Rhea-AI Summary

AmBase Corporation filed its quarterly report for the period ended September 30, 2025, reporting a net loss of $1.091 million for Q3 and $3.766 million for the nine months. Management states there is substantial doubt about the company’s ability to continue as a going concern based on current cash resources and expected needs.

Cash and cash equivalents were $239,000 at September 30, 2025, against total liabilities of $8.130 million, driven primarily by related‑party loans of $2.0 million (BARC Investments LLC) and $3.2 million (R.A. Bianco). Stockholders’ equity was a deficit of $7.891 million. Q3 operating expenses were $985,000, down from $1.523 million a year ago; interest expense for the nine months was $245,000.

The company continues multiple legal actions related to its former investment in the 111 West 57th Property. The court set a bench trial for November 30, 2026 in two matters, with interim decisions issued on September 9, 2025 and appeal activity continuing. During 2025, AmBase recorded $124,000 of other income from an employee retention credit refund.